Crystalline Edg 2 Receptor Antagonist And Methods Of Making

Abstract: Described herein are crystalline forms of 2-(4-methoxy-3-(3-methylphenethoxy)benzamido)-2,3- dihydro-1H-indene-2-carboxylic acid and methods of makingthe same. Such forms of 2-(4- methoxy-3-(3-methylphenethoxy)benzamido)-2,3-dihydro-1H-indene-2-carboxylic acid are useful in the preparation of pharmaceutical compositions for the treatment of diseases or conditions that would benefit by administration with an EDG-2 receptor antagonist compound.

Patent Information

Application #

Filing Date

06 March 2023

Publication Number

47/2023

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

SANOFI

46 Avenue de la Grande Armée Paris France 75017

Inventors

1. PERNERSTORFER, Josef

54 Rue La Boetie 75008 Paris

2. ROCCO, William

54 Rue La Boetie 75008 Paris

3. BRITTAIN, Jason

C/o Horizon Therapeutics Ireland Dac Connaught House, 1st Floor 1 Burlington Road Dublin, D04 C5Y6

Specification

Documents

Application Documents

#	Name	Date
1	202317014936.pdf	2023-03-06
2	202317014936-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [06-03-2023(online)].pdf	2023-03-06
3	202317014936-STATEMENT OF UNDERTAKING (FORM 3) [06-03-2023(online)].pdf	2023-03-06
4	202317014936-PROOF OF RIGHT [06-03-2023(online)].pdf	2023-03-06
5	202317014936-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [06-03-2023(online)].pdf	2023-03-06
6	202317014936-FORM 1 [06-03-2023(online)].pdf	2023-03-06
7	202317014936-DRAWINGS [06-03-2023(online)].pdf	2023-03-06
8	202317014936-DECLARATION OF INVENTORSHIP (FORM 5) [06-03-2023(online)].pdf	2023-03-06
9	202317014936-COMPLETE SPECIFICATION [06-03-2023(online)].pdf	2023-03-06
10	202317014936-FORM-26 [18-04-2023(online)].pdf	2023-04-18
11	202317014936-RELEVANT DOCUMENTS [29-04-2023(online)].pdf	2023-04-29
12	202317014936-POA [29-04-2023(online)].pdf	2023-04-29
13	202317014936-FORM 13 [29-04-2023(online)].pdf	2023-04-29
14	202317014936-AMENDED DOCUMENTS [29-04-2023(online)].pdf	2023-04-29
15	202317014936-FORM 3 [24-08-2023(online)].pdf	2023-08-24
16	202317014936-FORM 3 [29-02-2024(online)].pdf	2024-02-29
17	202317014936-FORM 18 [28-08-2024(online)].pdf	2024-08-28